Global Lurasidone Sales Market Market Report

Global Lurasidone Sales Market Report 2021

Report ID : RPT-121737BTNR | Industry : Pharma & Healthcare

Published On : January 2021 | Pages : 135 Pages

Global Lurasidone Sales Market Market Report

Description

A recently published report by QY Research titled Global Lurasidone Sales Market Report 2021 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Lurasidone market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.

The global Lurasidone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2022-2027.

The global Lurasidone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lurasidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.

Geographical Analysis:

Based on region, the global Lurasidone market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Lurasidone market are

  • Angelini Holding S.p.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • RemedyRepack?Inc.
  • Bushu Pharmaceutical, LTD.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Healthcare Pharmaceuticals Limited
  • Square Pharmaceuticals Ltd.
  • Incepta Pharmaceuticals Ltd.
     

Segment by Type

  • 20mg/tablet
  • 40mg/tablet
  • 60mg/tablet
  • 80mg/tablet
  • 120mg/tablet

Segment by Application

  • Hospital
  • Psychological Clinic
  • Others

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Lurasidone market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Lurasidone market.

• The market share of the global Lurasidone market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Lurasidone market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Lurasidone market.

Research Methodology:

This examination study included the broad utilization of both essential (primary) and auxiliary (secondary) information sources. The full process included the investigation of different elements influencing the business, including the administration strategy, market condition, market competition, past information, present patterns in the market, mechanical advancement, trending innovations and the specialized advancement in related industry, and market hazards, openings, market boundaries, and difficulties.

Market Size Estimation:

Base up and top-down ways are utilized to know the product size of the international market and gauge the market size for Companies item portions and application. The market assessments in this report depend on the price of the product which excludes limits gave by the producer, merchant, distributor, or brokers. The rate parts, piece of the pie, and breakdown of the item fragments are determined based on competition doled out to every one of the sections based on their usage rate and normal cost. The territorial parts of the general product market and its sub-sections depend on the rate appropriation or usage of the given item in the particular district or nation.

Big companies in the market are recognized through auxiliary examination and their market incomes decided through primary and secondary research approaches. The secondary research incorporated the exploration of the yearly and budgetary reports of the top Company; while, the main research included meetings of key supposition pioneers and industry specialists.

All potential factors that impact the business sectors remembered for this examination study have been represented, seen in broad detail, checked through essential exploration, and investigated to get the last quantitative and subjective information. The market size for high-level business sectors and sub-portions is standardized, and the impact of swelling, financial slumps, and administrative and strategy changes or different elements are not represented in the market figure.

Data Source:
Secondary Sources

Secondary sources incorporate, for example, public statements, yearly reports, non-benefit associations, industry affiliations, legislative organizations and customs information, and so on. This exploration study includes the use of far-reaching optional sources, catalogs, information bases, for example, Bloomberg Business, Factiva (Dow Jones and Company), Wind Info, Hoovers, and TRADING ECONOMICS, and News Network, Federal Reserve Economic Data, yearly reports, BIS Statistics, ICIS; organization house archives; CAS (American Chemical Society); speculator introductions; and SEC filings of organizations. It was likewise used to acquire significant data about the top organizations, market grouping and division as indicated by industry patterns to the base generally level, and key improvements identified with market and innovation viewpoints.

Primary Sources

In the primary research different sources from both the flexibly and request sides were met to get subjective and quantitative data for this report. The primary sources from the supply side incorporate product company (and their rivals), supposition pioneers, industry specialists, research foundations, merchants, vendors, and dealers, just as the crude materials providers and makers and so on.

The primary sources from the demand side incorporate industry specialists, for example, business pioneers, advertising and deals chiefs, innovation and development chiefs, flexibly chain leader, market (item purchasers), and related key heads from different key organizations and associations working in the international market.

Primary research initiative was led to distinguish division types, item value run, crude materials supply product application, key company, and the downstream interest, industry status and standpoint, and key market elements, for example, options, impact factors, openings, market obstructions, industry patterns, and central member systems.

Table Of Content

1 Lurasidone Market Overview



    1.1 Lurasidone Product Scope



    1.2 Lurasidone Segment by Type



        1.2.1 Global Lurasidone Sales by Type (2016 & 2021 & 2027)



        1.2.2 20mg/tablet



        1.2.3 40mg/tablet



        1.2.4 60mg/tablet



        1.2.5 80mg/tablet



        1.2.6 120mg/tablet



    1.3 Lurasidone Segment by Application



        1.3.1 Global Lurasidone Sales Comparison by Application (2016 & 2021 & 2027)



        1.3.2 Hospital



        1.3.3 Psychological Clinic



        1.3.4 Others



    1.4 Lurasidone Market Estimates and Forecasts (2016-2027)



        1.4.1 Global Lurasidone Market Size in Value Growth Rate (2016-2027)



        1.4.2 Global Lurasidone Market Size in Volume Growth Rate (2016-2027)



        1.4.3 Global Lurasidone Price Trends (2016-2027)



 



2 Lurasidone Estimates and Forecasts by Region



    2.1 Global Lurasidone Market Size by Region: 2016 VS 2021 VS 2027



    2.2 Global Lurasidone Retrospective Market Scenario by Region (2016-2021)



        2.2.1 Global Lurasidone Sales Market Share by Region (2016-2021)



        2.2.2 Global Lurasidone Revenue Market Share by Region (2016-2021)



    2.3 Global Lurasidone Market Estimates and Forecasts by Region (2022-2027)



        2.3.1 Global Lurasidone Sales Estimates and Forecasts by Region (2022-2027)



        2.3.2 Global Lurasidone Revenue Forecast by Region (2022-2027)



    2.4 Geographic Market Analysis: Market Facts & Figures



        2.4.1 North America Lurasidone Estimates and Projections (2016-2027)



        2.4.2 Europe Lurasidone Estimates and Projections (2016-2027)



        2.4.3 China Lurasidone Estimates and Projections (2016-2027)



        2.4.4 Japan Lurasidone Estimates and Projections (2016-2027)



        2.4.5 Southeast Asia Lurasidone Estimates and Projections (2016-2027)



        2.4.6 India Lurasidone Estimates and Projections (2016-2027)



3 Global Lurasidone Competition Landscape by Players



    3.1 Global Top Lurasidone Players by Sales (2016-2021)



    3.2 Global Top Lurasidone Players by Revenue (2016-2021)



    3.3 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lurasidone as of 2020)



    3.4 Global Lurasidone Average Price by Company (2016-2021)



    3.5 Manufacturers Lurasidone Manufacturing Sites, Area Served, Product Type



    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans



4 Global Lurasidone Market Size by Type



    4.1 Global Lurasidone Historic Market Review by Type (2016-2021)



        4.1.1 Global Lurasidone Sales Market Share by Type (2016-2021)



        4.1.2 Global Lurasidone Revenue Market Share by Type (2016-2021)



        4.1.3 Global Lurasidone Price by Type (2016-2021)



    4.2 Global Lurasidone Market Estimates and Forecasts by Type (2022-2027)



        4.2.1 Global Lurasidone Sales Forecast by Type (2022-2027)



        4.2.2 Global Lurasidone Revenue Forecast by Type (2022-2027)



        4.2.3 Global Lurasidone Price Forecast by Type (2022-2027)



5 Global Lurasidone Market Size by Application



    5.1 Global Lurasidone Historic Market Review by Application (2016-2021)



        5.1.1 Global Lurasidone Sales Market Share by Application (2016-2021)



        5.1.2 Global Lurasidone Revenue Market Share by Application (2016-2021)



        5.1.3 Global Lurasidone Price by Application (2016-2021)



    5.2 Global Lurasidone Market Estimates and Forecasts by Application (2022-2027)



        5.2.1 Global Lurasidone Sales Forecast by Application (2022-2027)



        5.2.2 Global Lurasidone Revenue Forecast by Application (2022-2027)



        5.2.3 Global Lurasidone Price Forecast by Application (2022-2027)



 



6 North America Lurasidone Market Facts & Figures



    6.1 North America Lurasidone Sales by Company



        6.1.1 North America Lurasidone Sales by Company (2016-2021)



        6.1.2 North America Lurasidone Revenue by Company (2016-2021)



    6.2 North America Lurasidone Sales Breakdown by Type



        6.2.1 North America Lurasidone Sales Breakdown by Type (2016-2021)



        6.2.2 North America Lurasidone Sales Breakdown by Type (2022-2027)



    6.3 North America Lurasidone Sales Breakdown by Application



        6.3.1 North America Lurasidone Sales Breakdown by Application (2016-2021)



        6.3.2 North America Lurasidone Sales Breakdown by Application (2022-2027)



 



7 Europe Lurasidone Market Facts & Figures



    7.1 Europe Lurasidone Sales by Company



        7.1.1 Europe Lurasidone Sales by Company (2016-2021)



        7.1.2 Europe Lurasidone Revenue by Company (2016-2021)



    7.2 Europe Lurasidone Sales Breakdown by Type



        7.2.1 Europe Lurasidone Sales Breakdown by Type (2016-2021)



        7.2.2 Europe Lurasidone Sales Breakdown by Type (2022-2027)



    7.3 Europe Lurasidone Sales Breakdown by Application



        7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)



        7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)



 



8 China Lurasidone Market Facts & Figures



    8.1 China Lurasidone Sales by Company



        8.1.1 China Lurasidone Sales by Company (2016-2021)



        8.1.2 China Lurasidone Revenue by Company (2016-2021)



    8.2 China Lurasidone Sales Breakdown by Type



        8.2.1 China Lurasidone Sales Breakdown by Type (2016-2021)



        8.2.2 China Lurasidone Sales Breakdown by Type (2022-2027)



    8.3 China Lurasidone Sales Breakdown by Application



        8.3.1 China 248 Sales Breakdown by Application (2016-2021)



        8.3.2 China 248 Sales Breakdown by Application (2022-2027)



 



9 Japan Lurasidone Market Facts & Figures



    9.1 Japan Lurasidone Sales by Company



        9.1.1 Japan Lurasidone Sales by Company (2016-2021)



        9.1.2 Japan Lurasidone Revenue by Company (2016-2021)



    9.2 Japan Lurasidone Sales Breakdown by Type



        9.2.1 Japan Lurasidone Sales Breakdown by Type (2016-2021)



        9.2.2 Japan Lurasidone Sales Breakdown by Type (2022-2027)



    9.3 Japan Lurasidone Sales Breakdown by Application



        9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)



        9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)



 



10 Southeast Asia Lurasidone Market Facts & Figures



    10.1 Southeast Asia Lurasidone Sales by Company



        10.1.1 Southeast Asia Lurasidone Sales by Company (2016-2021)



        10.1.2 Southeast Asia Lurasidone Revenue by Company (2016-2021)



    10.2 Southeast Asia Lurasidone Sales Breakdown by Type



        10.2.1 Southeast Asia Lurasidone Sales Breakdown by Type (2016-2021)



        10.2.2 Southeast Asia Lurasidone Sales Breakdown by Type (2022-2027)



    10.3 Southeast Asia Lurasidone Sales Breakdown by Application



        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)



        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)



 



11 India Lurasidone Market Facts & Figures



    11.1 India Lurasidone Sales by Company



        11.1.1 India Lurasidone Sales by Company (2016-2021)



        11.1.2 India Lurasidone Revenue by Company (2016-2021)



    11.2 India Lurasidone Sales Breakdown by Type



        11.2.1 India Lurasidone Sales Breakdown by Type (2016-2021)



        11.2.2 India Lurasidone Sales Breakdown by Type (2022-2027)



    11.3 India Lurasidone Sales Breakdown by Application



        11.3.1 India Lurasidone Sales Breakdown by Application (2016-2021)



        11.3.2 India Lurasidone Sales Breakdown by Application (2022-2027)



 



12 Company Profiles and Key Figures in Lurasidone Business



    12.1 Angelini Holding S.p.A.



        12.1.1 Angelini Holding S.p.A. Corporation Information



        12.1.2 Angelini Holding S.p.A. Business Overview



        12.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.1.4 Angelini Holding S.p.A. Lurasidone Products Offered



        12.1.5 Angelini Holding S.p.A. Recent Development



    12.2 Sumitomo Dainippon Pharma Co., Ltd.



        12.2.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information



        12.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview



        12.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Products Offered



        12.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development



    12.3 RemedyRepack?Inc.



        12.3.1 RemedyRepack?Inc. Corporation Information



        12.3.2 RemedyRepack?Inc. Business Overview



        12.3.3 RemedyRepack?Inc. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.3.4 RemedyRepack?Inc. Lurasidone Products Offered



        12.3.5 RemedyRepack?Inc. Recent Development



    12.4 Bushu Pharmaceutical, LTD.



        12.4.1 Bushu Pharmaceutical, LTD. Corporation Information



        12.4.2 Bushu Pharmaceutical, LTD. Business Overview



        12.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.4.4 Bushu Pharmaceutical, LTD. Lurasidone Products Offered



        12.4.5 Bushu Pharmaceutical, LTD. Recent Development



    12.5 Zhejiang Hisun Pharmaceutical Co., Ltd.



        12.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information



        12.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview



        12.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Products Offered



        12.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development



    12.6 Healthcare Pharmaceuticals Limited



        12.6.1 Healthcare Pharmaceuticals Limited Corporation Information



        12.6.2 Healthcare Pharmaceuticals Limited Business Overview



        12.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.6.4 Healthcare Pharmaceuticals Limited Lurasidone Products Offered



        12.6.5 Healthcare Pharmaceuticals Limited Recent Development



    12.7 Square Pharmaceuticals Ltd.



        12.7.1 Square Pharmaceuticals Ltd. Corporation Information



        12.7.2 Square Pharmaceuticals Ltd. Business Overview



        12.7.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.7.4 Square Pharmaceuticals Ltd. Lurasidone Products Offered



        12.7.5 Square Pharmaceuticals Ltd. Recent Development



    12.8 Incepta Pharmaceuticals Ltd.



        12.8.1 Incepta Pharmaceuticals Ltd. Corporation Information



        12.8.2 Incepta Pharmaceuticals Ltd. Business Overview



        12.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)



        12.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Products Offered



        12.8.5 Incepta Pharmaceuticals Ltd. Recent Development



 



13 Lurasidone Manufacturing Cost Analysis



    13.1 Lurasidone Key Raw Materials Analysis



        13.1.1 Key Raw Materials



        13.1.2 Key Raw Materials Price Trend



        13.1.3 Key Suppliers of Raw Materials



    13.2 Proportion of Manufacturing Cost Structure



    13.3 Manufacturing Process Analysis of Lurasidone



    13.4 Lurasidone Industrial Chain Analysis



 



14 Marketing Channel, Distributors and Customers



    14.1 Marketing Channel



    14.2 Lurasidone Distributors List



    14.3 Lurasidone Customers



 



15 Market Dynamics



    15.1 Lurasidone Market Trends



    15.2 Lurasidone Drivers



    15.3 Lurasidone Market Challenges



    15.4 Lurasidone Market Restraints



 



16 Research Findings and Conclusion



 



17 Appendix



    17.1 Research Methodology



        17.1.1 Methodology/Research Approach



        17.1.2 Data Source



    17.2 Author List



    17.3 Disclaimer


Tables & Figures

Table 1. Global Lurasidone Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)



Table 2. Global Lurasidone Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)



Table 3. Global Lurasidone Market Size (US$ Million) by Region: 2016 VS 2021 &2027



Table 4. Global Lurasidone Sales (K Units) by Region (2016-2021)



Table 5. Global Lurasidone Sales Market Share by Region (2016-2021)



Table 6. Global Lurasidone Revenue (US$ Million) Market Share by Region (2016-2021))



Table 7. Global Lurasidone Revenue Share by Region (2016-2021)



Table 8. Global Lurasidone Sales (K Units) Forecast by Region (2022-2027)



Table 9. Global Lurasidone Sales Market Share Forecast by Region (2022-2027)



Table 10. Global Lurasidone Revenue (US$ Million) Forecast by Region (2022-2027)



Table 11. Global Lurasidone Revenue Share Forecast by Region (2022-2027)



Table 12. Global Lurasidone Sales (K Units) of Key Companies (2016-2021)



Table 13. Global Lurasidone Sales Share by Company (2016-2021)



Table 14. Global Lurasidone Revenue (US$ Million) by Company (2016-2021)



Table 15. Global Lurasidone Revenue Share by Company (2016-2021)



Table 16. Global Lurasidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lurasidone as of 2020)



Table 17. Global Lurasidone Average Price (US$/Unit) of Key Company (2016-2021)



Table 18. Manufacturers Lurasidone Manufacturing Sites and Area Served



Table 19. Manufacturers Lurasidone Product Type



Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans



Table 21. Global Lurasidone Sales (K Units) by Type (2016-2021)



Table 22. Global Lurasidone Sales Share by Type (2016-2021)



Table 23. Global Lurasidone Revenue (US$ Million) Market Share by Type (2016-2021)



Table 24. Global Lurasidone Price (US$/Unit) by Type (2016-2021)



Table 25. Global Lurasidone Sales Share by Type (2022-2027)



Table 26. Global Lurasidone Revenue (US$ Million) Market Share by Type (2022-2027)



Table 27. Global Lurasidone Revenue Share by Type (2022-2027)



Table 28. Global Lurasidone Price (US$/Unit) by Type (2022-2027)



Table 29. Global Lurasidone Sales (K Units) by Application (2016-2021)



Table 30. Global Lurasidone Sales Share by Application (2016-2021)



Table 31. Global Lurasidone Revenue (US$ Million) Market Share by Application (2016-2021)



Table 32. Global Lurasidone Price (US$/Unit) by Application (2016-2021)



Table 33. Global Lurasidone Sales (K Units) by Application (2022-2027)



Table 34. Global Lurasidone Sales Share by Application (2022-2027)



Table 35. Global Lurasidone Revenue (US$ Million) Market Share by Application (2022-2027)



Table 36. Global Lurasidone Revenue Share by Application (2022-2027)



Table 37. Global Lurasidone Price (US$/Unit) by Application (2022-2027)



Table 38. North America Lurasidone Sales (K Units) by Company (2016-2021)



Table 39. North America Lurasidone Sales Market Share by Company (2016-2021)



Table 40. North America Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 41. North America Lurasidone Revenue Market Share by Company (2016-2021)



Table 42. North America Lurasidone Sales by Type (2016-2021) & (K Units)



Table 43. North America Lurasidone Sales Market Share by Type (2016-2021)



Table 44. North America Lurasidone Sales by Type (2022-2027) & (K Units)



Table 45. North America Lurasidone Sales Market Share by Type (2022-2027)



Table 46. North America Lurasidone Sales by Application (2016-2021) & (K Units)



Table 47. North America Lurasidone Sales Market Share by Application (2016-2021)



Table 48. North America Lurasidone Sales by Application (2022-2027) & (K Units)



Table 49. North America Lurasidone Sales Market Share by Application (2022-2027)



Table 50. Europe Lurasidone Sales (K Units) by Company (2016-2021)



Table 51. Europe Lurasidone Sales Market Share by Company (2016-2021)



Table 52. Europe Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 53. Europe Lurasidone Revenue Market Share by Company (2016-2021)



Table 54. Europe Lurasidone Sales by Type (2016-2021) & (K Units)



Table 55. Europe Lurasidone Sales Market Share by Type (2016-2021)



Table 56. Europe Lurasidone Sales by Type (2022-2027) & (K Units)



Table 57. Europe Lurasidone Sales Market Share by Type (2022-2027)



Table 58. Europe Lurasidone Sales by Application (2016-2021) & (K Units)



Table 59. Europe Lurasidone Sales Market Share by Application (2016-2021)



Table 60. Europe Lurasidone Sales by Application (2022-2027) & (K Units)



Table 61. Europe Lurasidone Sales Market Share by Application (2022-2027)



Table 62. China Lurasidone Sales (K Units) by Company (2016-2021)



Table 63. China Lurasidone Sales Market Share by Company (2016-2021)



Table 64. China Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 65. China Lurasidone Revenue Market Share by Company (2016-2021)



Table 66. China Lurasidone Sales by Type (2016-2021) & (K Units)



Table 67. China Lurasidone Sales Market Share by Type (2016-2021)



Table 68. China Lurasidone Sales by Type (2022-2027) & (K Units)



Table 69. China Lurasidone Sales Market Share by Type (2022-2027)



Table 70. China Lurasidone Sales by Application (2016-2021) & (K Units)



Table 71. China Lurasidone Sales Market Share by Application (2016-2021)



Table 72. China Lurasidone Sales by Application (2022-2027) & (K Units)



Table 73. China Lurasidone Sales Market Share by Application (2022-2027)



Table 74. Japan Lurasidone Sales (K Units) by Company (2016-2021)



Table 75. Japan Lurasidone Sales Market Share by Company (2016-2021)



Table 76. Japan Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 77. Japan Lurasidone Revenue Market Share by Company (2016-2021)



Table 78. Japan Lurasidone Sales by Type (2016-2021) & (K Units)



Table 79. Japan Lurasidone Sales Market Share by Type (2016-2021)



Table 80. Japan Lurasidone Sales by Type (2022-2027) & (K Units)



Table 81. Japan Lurasidone Sales Market Share by Type (2022-2027)



Table 82. Japan Lurasidone Sales by Application (2016-2021) & (K Units)



Table 83. Japan Lurasidone Sales Market Share by Application (2016-2021)



Table 84. Japan Lurasidone Sales by Application (2022-2027) & (K Units)



Table 85. Japan Lurasidone Sales Market Share by Application (2022-2027)



Table 86. Southeast Asia Lurasidone Sales (K Units) by Company (2016-2021)



Table 87. Southeast Asia Lurasidone Sales Market Share by Company (2016-2021)



Table 88. Southeast Asia Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 89. Southeast Asia Lurasidone Revenue Market Share by Company (2016-2021)



Table 90. Southeast Asia Lurasidone Sales by Type (2016-2021) & (K Units)



Table 91. Southeast Asia Lurasidone Sales Market Share by Type (2016-2021)



Table 92. Southeast Asia Lurasidone Sales by Type (2022-2027) & (K Units)



Table 93. Southeast Asia Lurasidone Sales Market Share by Type (2022-2027)



Table 94. Southeast Asia Lurasidone Sales by Application (2016-2021) & (K Units)



Table 95. Southeast Asia Lurasidone Sales Market Share by Application (2016-2021)



Table 96. Southeast Asia Lurasidone Sales by Application (2022-2027) & (K Units)



Table 97. Southeast Asia Lurasidone Sales Market Share by Application (2022-2027)



Table 98. India Lurasidone Sales (K Units) by Company (2016-2021)



Table 99. India Lurasidone Sales Market Share by Company (2016-2021)



Table 100. India Lurasidone Revenue by Company (2016-2021) & (US$ Million)



Table 101. India Lurasidone Revenue Market Share by Company (2016-2021)



Table 102. India Lurasidone Sales by Type (2016-2021) & (K Units)



Table 103. India Lurasidone Sales Market Share by Type (2016-2021)



Table 104. India Lurasidone Sales by Type (2022-2027) & (K Units)



Table 105. India Lurasidone Sales Market Share by Type (2022-2027)



Table 106. India Lurasidone Sales by Application (2016-2021) & (K Units)



Table 107. India Lurasidone Sales Market Share by Application (2016-2021)



Table 108. India Lurasidone Sales by Application (2022-2027) & (K Units)



Table 109. India Lurasidone Sales Market Share by Application (2022-2027)



Table 110. Angelini Holding S.p.A. Corporation Information



Table 111. Angelini Holding S.p.A. Description and Business Overview



Table 112. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 113. Angelini Holding S.p.A. Lurasidone Product



Table 114. Angelini Holding S.p.A. Recent Development



Table 115. Sumitomo Dainippon Pharma Co., Ltd. Corporation Information



Table 116. Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview



Table 117. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 118. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product



Table 119. Sumitomo Dainippon Pharma Co., Ltd. Recent Development



Table 120. RemedyRepack?Inc. Corporation Information



Table 121. RemedyRepack?Inc. Description and Business Overview



Table 122. RemedyRepack?Inc. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 123. RemedyRepack?Inc. Lurasidone Product



Table 124. RemedyRepack?Inc. Recent Development



Table 125. Bushu Pharmaceutical, LTD. Corporation Information



Table 126. Bushu Pharmaceutical, LTD. Description and Business Overview



Table 127. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 128. Bushu Pharmaceutical, LTD. Lurasidone Product



Table 129. Bushu Pharmaceutical, LTD. Recent Development



Table 130. Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information



Table 131. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview



Table 132. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 133. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product



Table 134. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development



Table 135. Healthcare Pharmaceuticals Limited Corporation Information



Table 136. Healthcare Pharmaceuticals Limited Description and Business Overview



Table 137. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 138. Healthcare Pharmaceuticals Limited Lurasidone Product



Table 139. Healthcare Pharmaceuticals Limited Recent Development



Table 140. Square Pharmaceuticals Ltd. Corporation Information



Table 141. Square Pharmaceuticals Ltd. Description and Business Overview



Table 142. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 143. Square Pharmaceuticals Ltd. Lurasidone Product



Table 144. Square Pharmaceuticals Ltd. Recent Development



Table 145. Incepta Pharmaceuticals Ltd. Corporation Information



Table 146. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)



Table 147. Incepta Pharmaceuticals Ltd. Description and Business Overview



Table 148. Incepta Pharmaceuticals Ltd. Lurasidone Product



Table 149. Incepta Pharmaceuticals Ltd. Recent Development



Table 150. Production Base and Market Concentration Rate of Raw Material



Table 151. Key Suppliers of Raw Materials



Table 152. Lurasidone Distributors List



Table 153. Lurasidone Customers List



Table 154. Lurasidone Market Trends



Table 155. Lurasidone Market Drivers



Table 156. Lurasidone Market Challenges



Table 157. Lurasidone Market Restraints



Table 158. Research Programs/Design for This Report



Table 159. Key Data Information from Secondary Sources



Table 160. Key Data Information from Primary Sources



List of Figures



Figure 1. Lurasidone Product Picture



Figure 2. Global Lurasidone Sales Market Share by Type in 2021 & 2027



Figure 3. Type I Product Picture



Figure 4. Type II Product Picture



Figure 5. Global Lurasidone Sales Market Share by Application in 2021 & 2027



Figure 6. Hospital Examples



Figure 7. Psychological Clinic Examples



Figure 8. Others Examples



Figure 9. Global Lurasidone Sales, (US$ Million), 2016 VS 2021 VS 2027



Figure 10. Global Lurasidone Sales Growth Rate (2016-2027) & (US$ Million)



Figure 11. Global Lurasidone Sales (K Units) Growth Rate (2016-2027)



Figure 12. Global Lurasidone Price Trends Growth Rate (2016-2027) (US$/Unit)



Figure 13. Global Lurasidone Revenue Market Share by Region: 2016 VS 2021



Figure 14. Global Lurasidone Revenue Market Share by Region: 2021 VS 2027



Figure 15. North America Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 16. North America Lurasidone Sales (K Units) Growth Rate (2016-2027)



Figure 17. Europe Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 18. Europe Lurasidone Sales (Million USD) Growth Rate (2016-2027)



Figure 19. China Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 20. China Lurasidone Sales (Million USD) and Growth Rate (2016-2027)



Figure 21. Japan Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 22. Japan Lurasidone Sales (Million USD) Growth Rate (2016-2027)



Figure 23. Southeast Asia Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 24. Southeast Asia Lurasidone Sales (Million USD) Growth Rate (2016-2027)



Figure 25. India Lurasidone Revenue (Million USD) Growth Rate (2016-2027)



Figure 26. India Lurasidone Sales (Million USD) Growth Rate (2016-2027)



Figure 27. Global 5 Largest Lurasidone Players Market Share by Revenue in Lurasidone: 2016 & 2020



Figure 28. Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020



Figure 29. Global Lurasidone Revenue Share by Type (2016-2021)



Figure 30. Global Lurasidone Revenue Growth Rate by Type in 2016 & 2020



Figure 31. Global Lurasidone Revenue Share by Application (2016-2021)



Figure 32. Global Lurasidone Revenue Growth Rate by Application in 2016 & 2020



Figure 33. North America Lurasidone Sales Market Share by Type in 2020



Figure 34. North America Lurasidone Sales Market Share by Application in 2020



Figure 35. Europe Lurasidone Sales Market Share by Type in 2020



Figure 36. Europe Lurasidone Sales Market Share by Application in 2020



Figure 37. China Lurasidone Sales Market Share by Type in 2020



Figure 38. China Lurasidone Sales Market Share by Application in 2020



Figure 39. Japan Lurasidone Sales Market Share by Type in 2020



Figure 40. Japan Lurasidone Sales Market Share by Application in 2020



Figure 41. Southeast Asia Lurasidone Sales Market Share by Type in 2020



Figure 42. Southeast Asia Lurasidone Sales Market Share by Application in 2020



Figure 43. India Lurasidone Sales Market Share by Type in 2020



Figure 44. India Lurasidone Sales Market Share by Application in 2020



Figure 45. Key Raw Materials Price Trend



Figure 46. Manufacturing Cost Structure of Lurasidone



Figure 47. Manufacturing Process Analysis of Lurasidone



Figure 48. Lurasidone Industrial Chain Analysis



Figure 49. Channels of Distribution



Figure 50. Distributors Profiles



Figure 51. Bottom-up and Top-down Approaches for This Report



Figure 52. Data Triangulation



Figure 53. Key Executives Interviewed


Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Our Client

Beathan Reports - Market Research Report Reseller

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1-551 233 6800 (USA Number)

Email: [email protected]